Spots Global Cancer Trial Database for hypofractionated radiation
Every month we try and update this database with for hypofractionated radiation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam | NCT05486936 | Breast Cancer | hypofractionate... | 18 Years - 75 Years | Ruijin Hospital | |
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer | NCT04683653 | Endometrial Can... | Hypofractionate... Clinical Follow... | 18 Years - | University of Chicago | |
Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery | NCT03320421 | Breast Cancer F... | Radiation thera... | 18 Years - 70 Years | ChineseAMS | |
Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma | NCT03598218 | Nasopharyngeal ... | Hypofraction ra... Standard dose I... | 18 Years - 70 Years | Guilin Medical University, China | |
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study | NCT05857631 | Cervical Cancer Endometrial Can... | Hypofractionate... Cisplatin Vaginal brachyt... | 18 Years - 80 Years | Tata Memorial Centre | |
Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer | NCT01505075 | Prostate Cancer | Hypofractionate... | 18 Years - | Sunnybrook Health Sciences Centre | |
Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma | NCT03598218 | Nasopharyngeal ... | Hypofraction ra... Standard dose I... | 18 Years - 70 Years | Guilin Medical University, China | |
Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer | NCT01505075 | Prostate Cancer | Hypofractionate... | 18 Years - | Sunnybrook Health Sciences Centre | |
Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery | NCT03320421 | Breast Cancer F... | Radiation thera... | 18 Years - 70 Years | ChineseAMS | |
Hypofractionated Radiation Therapy in Patients With Breast Cancer | NCT04075058 | Breast Cancer | Hypofractionate... | 18 Years - 80 Years | PGIMER | |
RADVAX™: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy | NCT02880345 | Urothelial Canc... | PEMBROLIZUMAB hypofractionate... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Hypofractionated Radiation Therapy in Patients With Breast Cancer | NCT04075058 | Breast Cancer | Hypofractionate... | 18 Years - 80 Years | PGIMER | |
Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial | NCT03082846 | Glioma Radiotherapy, I... Maximum Tolerat... | hypofractionate... Temozolomide ch... | 18 Years - 70 Years | The Second Hospital of Hebei Medical University | |
RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam | NCT05486936 | Breast Cancer | hypofractionate... | 18 Years - 75 Years | Ruijin Hospital | |
Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer | NCT01505075 | Prostate Cancer | Hypofractionate... | 18 Years - | Sunnybrook Health Sciences Centre |